 Juleen Zierath
Concepts (432)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Muscle, Skeletal | 79 | 2017 | 489 | 15.200 |
Why?
| | Glucose | 35 | 2017 | 302 | 5.040 |
Why?
| | Diabetes Mellitus, Type 2 | 29 | 2015 | 410 | 4.670 |
Why?
| | Insulin Resistance | 22 | 2017 | 310 | 4.560 |
Why?
| | Insulin | 32 | 2014 | 560 | 3.960 |
Why?
| | Exercise | 15 | 2017 | 532 | 3.590 |
Why?
| | AMP-Activated Protein Kinases | 17 | 2016 | 45 | 3.430 |
Why?
| | Signal Transduction | 33 | 2017 | 2264 | 3.040 |
Why?
| | Energy Metabolism | 11 | 2015 | 283 | 2.510 |
Why?
| | Protein-Serine-Threonine Kinases | 15 | 2014 | 316 | 2.400 |
Why?
| | Adenylate Kinase | 4 | 2017 | 13 | 2.240 |
Why?
| | Muscle Fibers, Skeletal | 13 | 2017 | 55 | 1.990 |
Why?
| | Physical Conditioning, Animal | 7 | 2015 | 29 | 1.930 |
Why?
| | Obesity | 14 | 2015 | 874 | 1.730 |
Why?
| | Mitochondria | 8 | 2017 | 262 | 1.720 |
Why?
| | Diabetes Mellitus | 5 | 2015 | 391 | 1.660 |
Why?
| | Lipid Metabolism | 9 | 2017 | 136 | 1.590 |
Why?
| | Multienzyme Complexes | 6 | 2008 | 73 | 1.560 |
Why?
| | Animals | 56 | 2017 | 14634 | 1.500 |
Why?
| | Phosphorylation | 19 | 2017 | 663 | 1.500 |
Why?
| | GTPase-Activating Proteins | 6 | 2014 | 43 | 1.340 |
Why?
| | Leptin | 3 | 2014 | 52 | 1.310 |
Why?
| | Muscle Contraction | 8 | 2014 | 130 | 1.290 |
Why?
| | Mice | 36 | 2017 | 7297 | 1.280 |
Why?
| | Diacylglycerol Kinase | 3 | 2015 | 5 | 1.200 |
Why?
| | Glycogen | 10 | 2017 | 29 | 1.190 |
Why?
| | Proto-Oncogene Proteins c-akt | 9 | 2010 | 144 | 1.190 |
Why?
| | Humans | 75 | 2017 | 33371 | 1.140 |
Why?
| | Heat-Shock Proteins | 2 | 2013 | 60 | 1.090 |
Why?
| | Protein Kinase C | 6 | 2017 | 102 | 1.090 |
Why?
| | Blood Glucose | 10 | 2015 | 386 | 1.080 |
Why?
| | Male | 48 | 2017 | 16846 | 1.040 |
Why?
| | DNA Methylation | 7 | 2015 | 172 | 1.040 |
Why?
| | Gene Silencing | 5 | 2012 | 252 | 1.000 |
Why?
| | Physical Endurance | 4 | 2017 | 40 | 1.000 |
Why?
| | Phosphoproteins | 6 | 2010 | 185 | 0.980 |
Why?
| | Adaptation, Physiological | 3 | 2017 | 75 | 0.910 |
Why?
| | Interleukin-6 | 7 | 2014 | 231 | 0.880 |
Why?
| | Fatty Acids | 5 | 2017 | 134 | 0.870 |
Why?
| | Transcription Factors | 11 | 2014 | 1222 | 0.850 |
Why?
| | Hypoglycemic Agents | 7 | 2013 | 160 | 0.850 |
Why?
| | Motor Activity | 3 | 2015 | 311 | 0.820 |
Why?
| | Protein Kinases | 6 | 2008 | 140 | 0.800 |
Why?
| | Enzyme Inhibitors | 5 | 2014 | 280 | 0.800 |
Why?
| | Mice, Inbred C57BL | 15 | 2017 | 2256 | 0.800 |
Why?
| | Periodicals as Topic | 2 | 2015 | 97 | 0.800 |
Why?
| | Calcineurin | 2 | 2009 | 21 | 0.790 |
Why?
| | Aminoimidazole Carboxamide | 9 | 2013 | 12 | 0.770 |
Why?
| | Diabetes Mellitus, Experimental | 5 | 2015 | 149 | 0.750 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2016 | 81 | 0.720 |
Why?
| | Mice, Transgenic | 10 | 2016 | 933 | 0.710 |
Why?
| | Health | 1 | 2015 | 26 | 0.710 |
Why?
| | Ribonucleotides | 9 | 2013 | 14 | 0.700 |
Why?
| | Phosphotransferases | 2 | 2005 | 15 | 0.700 |
Why?
| | Subcutaneous Fat | 1 | 2015 | 19 | 0.700 |
Why?
| | Cells, Cultured | 16 | 2015 | 1760 | 0.690 |
Why?
| | Gene Expression Regulation | 11 | 2015 | 1248 | 0.680 |
Why?
| | RNA, Small Interfering | 7 | 2015 | 576 | 0.680 |
Why?
| | Cell Differentiation | 4 | 2014 | 1032 | 0.670 |
Why?
| | Research | 1 | 2015 | 143 | 0.660 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2014 | 98 | 0.650 |
Why?
| | Tumor Necrosis Factor-alpha | 6 | 2014 | 485 | 0.640 |
Why?
| | Weight Loss | 3 | 2015 | 205 | 0.630 |
Why?
| | STAT3 Transcription Factor | 2 | 2012 | 33 | 0.620 |
Why?
| | Nuclear Proteins | 4 | 2013 | 682 | 0.600 |
Why?
| | Epigenesis, Genetic | 4 | 2015 | 197 | 0.580 |
Why?
| | Muscle Fibers, Fast-Twitch | 2 | 2009 | 9 | 0.570 |
Why?
| | Gene Expression | 9 | 2015 | 606 | 0.540 |
Why?
| | Ceramides | 2 | 2008 | 15 | 0.510 |
Why?
| | Tissue Extracts | 1 | 2010 | 12 | 0.500 |
Why?
| | Proteome | 3 | 2015 | 67 | 0.490 |
Why?
| | Glucose Transporter Type 4 | 7 | 2012 | 55 | 0.490 |
Why?
| | Glucose Transport Proteins, Facilitative | 1 | 2009 | 5 | 0.490 |
Why?
| | DNA (Cytosine-5-)-Methyltransferase | 1 | 2009 | 19 | 0.480 |
Why?
| | Female | 25 | 2015 | 18252 | 0.480 |
Why?
| | Biological Transport | 9 | 2013 | 237 | 0.480 |
Why?
| | Rats | 13 | 2012 | 1835 | 0.470 |
Why?
| | Adipose Tissue, Brown | 1 | 2009 | 27 | 0.460 |
Why?
| | Mitochondrial Proteins | 6 | 2014 | 65 | 0.450 |
Why?
| | Muscle Proteins | 3 | 2003 | 100 | 0.440 |
Why?
| | Carboxy-Lyases | 1 | 2008 | 4 | 0.440 |
Why?
| | Mice, Knockout | 10 | 2016 | 1576 | 0.430 |
Why?
| | Trans-Activators | 5 | 2012 | 274 | 0.430 |
Why?
| | Down-Regulation | 2 | 2010 | 248 | 0.420 |
Why?
| | Middle Aged | 23 | 2015 | 9606 | 0.420 |
Why?
| | CpG Islands | 4 | 2015 | 167 | 0.420 |
Why?
| | Glucose Intolerance | 3 | 2015 | 63 | 0.410 |
Why?
| | Hyperglycemia | 2 | 2008 | 88 | 0.400 |
Why?
| | Adipose Tissue | 4 | 2006 | 214 | 0.390 |
Why?
| | Mitogen-Activated Protein Kinases | 4 | 2008 | 157 | 0.390 |
Why?
| | Enzyme Activation | 8 | 2014 | 332 | 0.390 |
Why?
| | Physical Exertion | 2 | 2013 | 64 | 0.390 |
Why?
| | Adenosine Monophosphate | 2 | 2005 | 15 | 0.390 |
Why?
| | Contractile Proteins | 1 | 2006 | 10 | 0.380 |
Why?
| | RNA, Messenger | 12 | 2015 | 1262 | 0.380 |
Why?
| | Gene Expression Profiling | 5 | 2014 | 489 | 0.380 |
Why?
| | Muscle Cells | 3 | 2014 | 15 | 0.380 |
Why?
| | Pancreas Transplantation | 1 | 2006 | 23 | 0.370 |
Why?
| | Protein Subunits | 5 | 2014 | 142 | 0.360 |
Why?
| | Promoter Regions, Genetic | 4 | 2014 | 597 | 0.360 |
Why?
| | Insulin Receptor Substrate Proteins | 4 | 2007 | 41 | 0.360 |
Why?
| | Proto-Oncogene Proteins | 5 | 2005 | 271 | 0.360 |
Why?
| | Microfilament Proteins | 1 | 2006 | 78 | 0.360 |
Why?
| | Mice, Obese | 3 | 2014 | 32 | 0.350 |
Why?
| | Adult | 17 | 2015 | 9442 | 0.350 |
Why?
| | Deoxyglucose | 4 | 2012 | 29 | 0.350 |
Why?
| | Metformin | 1 | 2005 | 35 | 0.340 |
Why?
| | Hypertrophy | 2 | 2016 | 20 | 0.340 |
Why?
| | Triglycerides | 4 | 2017 | 210 | 0.340 |
Why?
| | Thiazolidinediones | 1 | 2005 | 50 | 0.340 |
Why?
| | Circadian Rhythm | 3 | 2017 | 270 | 0.330 |
Why?
| | Fatty Acids, Nonesterified | 3 | 2012 | 44 | 0.330 |
Why?
| | beta-Alanine | 1 | 2003 | 7 | 0.320 |
Why?
| | Lipids | 4 | 2011 | 234 | 0.320 |
Why?
| | Cardiac Output, Low | 1 | 2003 | 8 | 0.310 |
Why?
| | Intracellular Signaling Peptides and Proteins | 3 | 2013 | 215 | 0.300 |
Why?
| | Bicycling | 1 | 2003 | 13 | 0.300 |
Why?
| | Metabolic Diseases | 2 | 2014 | 32 | 0.300 |
Why?
| | Case-Control Studies | 5 | 2014 | 630 | 0.300 |
Why?
| | Organ Size | 2 | 2016 | 131 | 0.300 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2004 | 99 | 0.300 |
Why?
| | Gastric Bypass | 2 | 2014 | 61 | 0.300 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2004 | 102 | 0.300 |
Why?
| | Glycolysis | 4 | 2013 | 35 | 0.300 |
Why?
| | Pyrazines | 2 | 2014 | 20 | 0.290 |
Why?
| | Boronic Acids | 2 | 2014 | 22 | 0.290 |
Why?
| | Receptor, Insulin | 3 | 2010 | 32 | 0.290 |
Why?
| | Sterol Regulatory Element Binding Protein 1 | 2 | 2017 | 15 | 0.290 |
Why?
| | Isoenzymes | 5 | 2009 | 140 | 0.290 |
Why?
| | PPAR delta | 3 | 2006 | 6 | 0.280 |
Why?
| | Gene Expression Regulation, Enzymologic | 3 | 2014 | 120 | 0.280 |
Why?
| | Overweight | 2 | 2015 | 172 | 0.270 |
Why?
| | Glucagon | 2 | 2014 | 22 | 0.270 |
Why?
| | Pyrones | 3 | 2012 | 4 | 0.270 |
Why?
| | Acetyl-CoA Carboxylase | 3 | 2014 | 6 | 0.270 |
Why?
| | Fasting | 2 | 2012 | 41 | 0.270 |
Why?
| | Autocrine Communication | 2 | 2013 | 27 | 0.270 |
Why?
| | Sodium-Potassium-Exchanging ATPase | 2 | 2012 | 19 | 0.270 |
Why?
| | Glucose Tolerance Test | 5 | 2015 | 80 | 0.260 |
Why?
| | Thiophenes | 3 | 2012 | 42 | 0.260 |
Why?
| | Oxygen Consumption | 5 | 2013 | 204 | 0.230 |
Why?
| | Metabolic Networks and Pathways | 2 | 2017 | 39 | 0.230 |
Why?
| | Rats, Wistar | 4 | 2008 | 205 | 0.220 |
Why?
| | Diglycerides | 2 | 2008 | 14 | 0.220 |
Why?
| | MicroRNAs | 2 | 2014 | 461 | 0.220 |
Why?
| | Immunoblotting | 3 | 2008 | 188 | 0.210 |
Why?
| | Young Adult | 6 | 2015 | 2072 | 0.210 |
Why?
| | Quadriceps Muscle | 1 | 2017 | 7 | 0.210 |
Why?
| | Athletes | 1 | 2017 | 9 | 0.210 |
Why?
| | Exercise Therapy | 2 | 2015 | 38 | 0.200 |
Why?
| | Gene Knockdown Techniques | 1 | 2017 | 138 | 0.200 |
Why?
| | Liver | 3 | 2012 | 550 | 0.190 |
Why?
| | Walking | 2 | 2015 | 109 | 0.190 |
Why?
| | Kinetics | 5 | 2013 | 713 | 0.190 |
Why?
| | Suppressor of Cytokine Signaling Proteins | 2 | 2012 | 10 | 0.190 |
Why?
| | Bariatric Surgery | 1 | 2015 | 28 | 0.180 |
Why?
| | Sleep Deprivation | 1 | 2015 | 18 | 0.180 |
Why?
| | Biopsy | 4 | 2011 | 250 | 0.180 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 2 | 2007 | 35 | 0.180 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 2 | 2007 | 33 | 0.170 |
Why?
| | History, 21st Century | 1 | 2015 | 81 | 0.170 |
Why?
| | Carotid Arteries | 1 | 2015 | 56 | 0.170 |
Why?
| | Protein Biosynthesis | 1 | 2017 | 270 | 0.170 |
Why?
| | Cell Line | 4 | 2014 | 1732 | 0.170 |
Why?
| | Transfection | 4 | 2015 | 631 | 0.170 |
Why?
| | Cardiovascular Physiological Phenomena | 1 | 2014 | 7 | 0.170 |
Why?
| | Kynurenine | 1 | 2014 | 3 | 0.170 |
Why?
| | Monosaccharide Transport Proteins | 3 | 2003 | 42 | 0.170 |
Why?
| | Protein Carbonylation | 1 | 2014 | 3 | 0.170 |
Why?
| | Manometry | 1 | 2014 | 9 | 0.170 |
Why?
| | Lipid Peroxidation | 1 | 2014 | 64 | 0.170 |
Why?
| | Sequence Analysis, DNA | 2 | 2013 | 314 | 0.170 |
Why?
| | History, 20th Century | 1 | 2015 | 168 | 0.170 |
Why?
| | Methotrexate | 1 | 2014 | 71 | 0.170 |
Why?
| | Muscles | 1 | 2015 | 144 | 0.170 |
Why?
| | Oxidation-Reduction | 2 | 2006 | 232 | 0.170 |
Why?
| | Gene Regulatory Networks | 1 | 2014 | 77 | 0.160 |
Why?
| | Angiography | 1 | 2014 | 105 | 0.160 |
Why?
| | Caloric Restriction | 1 | 2014 | 8 | 0.160 |
Why?
| | DNA-Binding Proteins | 5 | 2014 | 1022 | 0.160 |
Why?
| | Sleep | 1 | 2015 | 83 | 0.160 |
Why?
| | Oxidative Stress | 2 | 2014 | 250 | 0.160 |
Why?
| | Nicotinamide Phosphoribosyltransferase | 1 | 2013 | 3 | 0.160 |
Why?
| | Interleukin-13 | 1 | 2013 | 22 | 0.160 |
Why?
| | Computational Biology | 1 | 2015 | 218 | 0.160 |
Why?
| | Anti-Obesity Agents | 1 | 2013 | 4 | 0.160 |
Why?
| | Cell Hypoxia | 2 | 2012 | 29 | 0.160 |
Why?
| | Glucose Clamp Technique | 2 | 2004 | 68 | 0.160 |
Why?
| | RNA Interference | 2 | 2014 | 501 | 0.160 |
Why?
| | Muscle Development | 1 | 2013 | 43 | 0.150 |
Why?
| | Oxidative Phosphorylation | 1 | 2013 | 31 | 0.150 |
Why?
| | Transcription Initiation Site | 1 | 2013 | 40 | 0.150 |
Why?
| | Obesity, Morbid | 1 | 2014 | 61 | 0.150 |
Why?
| | Janus Kinase 2 | 1 | 2012 | 11 | 0.150 |
Why?
| | Organ Specificity | 1 | 2013 | 170 | 0.150 |
Why?
| | Mitochondria, Muscle | 3 | 2012 | 12 | 0.150 |
Why?
| | Genetic Variation | 1 | 2014 | 238 | 0.150 |
Why?
| | Gluconeogenesis | 1 | 2012 | 12 | 0.150 |
Why?
| | Fibroblasts | 2 | 2011 | 286 | 0.140 |
Why?
| | Homeostasis | 3 | 2015 | 222 | 0.140 |
Why?
| | Palmitic Acid | 1 | 2011 | 8 | 0.140 |
Why?
| | Stress, Psychological | 1 | 2014 | 259 | 0.140 |
Why?
| | Cross-Over Studies | 2 | 2015 | 101 | 0.140 |
Why?
| | Genome, Human | 1 | 2013 | 153 | 0.140 |
Why?
| | PPAR alpha | 2 | 2014 | 16 | 0.140 |
Why?
| | Protein Kinase Inhibitors | 2 | 2009 | 73 | 0.140 |
Why?
| | Immunohistochemistry | 2 | 2013 | 744 | 0.130 |
Why?
| | Fibroblast Growth Factors | 1 | 2011 | 32 | 0.130 |
Why?
| | Body Weight | 2 | 2009 | 349 | 0.130 |
Why?
| | TNF-Related Apoptosis-Inducing Ligand | 1 | 2010 | 12 | 0.130 |
Why?
| | Sirtuin 1 | 1 | 2010 | 11 | 0.130 |
Why?
| | Depression | 1 | 2014 | 382 | 0.120 |
Why?
| | Protease Inhibitors | 1 | 2010 | 53 | 0.120 |
Why?
| | Diacylglycerol O-Acyltransferase | 1 | 2009 | 3 | 0.120 |
Why?
| | Glycogen Synthase Kinase 3 | 1 | 2010 | 40 | 0.120 |
Why?
| | Fatty Acid Transport Proteins | 1 | 2009 | 6 | 0.120 |
Why?
| | Benzylamines | 1 | 2009 | 9 | 0.120 |
Why?
| | Acyltransferases | 1 | 2009 | 18 | 0.120 |
Why?
| | Electron Transport | 1 | 2009 | 23 | 0.120 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2009 | 22 | 0.120 |
Why?
| | Ion Channels | 2 | 2008 | 65 | 0.120 |
Why?
| | Cytotoxicity, Immunologic | 1 | 2010 | 155 | 0.120 |
Why?
| | Forkhead Transcription Factors | 1 | 2010 | 77 | 0.120 |
Why?
| | Base Sequence | 2 | 2010 | 1270 | 0.120 |
Why?
| | Body Mass Index | 4 | 2011 | 727 | 0.120 |
Why?
| | DNA, Mitochondrial | 1 | 2009 | 39 | 0.120 |
Why?
| | Adipose Tissue, White | 1 | 2009 | 32 | 0.110 |
Why?
| | Multiple Myeloma | 1 | 2010 | 78 | 0.110 |
Why?
| | Killer Cells, Natural | 1 | 2010 | 185 | 0.110 |
Why?
| | Hyperlipidemias | 1 | 2009 | 48 | 0.110 |
Why?
| | Ionophores | 1 | 2008 | 11 | 0.110 |
Why?
| | Sulfonamides | 1 | 2009 | 80 | 0.110 |
Why?
| | Ionomycin | 1 | 2008 | 14 | 0.110 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 3 | 2005 | 106 | 0.110 |
Why?
| | Membrane Proteins | 2 | 2005 | 645 | 0.110 |
Why?
| | Organ Culture Techniques | 1 | 2008 | 46 | 0.110 |
Why?
| | 11-beta-Hydroxysteroid Dehydrogenase Type 1 | 2 | 2009 | 2 | 0.110 |
Why?
| | PPAR gamma | 1 | 2009 | 58 | 0.110 |
Why?
| | Glucagon-Secreting Cells | 1 | 2008 | 15 | 0.110 |
Why?
| | Coenzyme A | 1 | 2008 | 6 | 0.110 |
Why?
| | Acetyl Coenzyme A | 1 | 2008 | 10 | 0.110 |
Why?
| | I-kappa B Kinase | 1 | 2008 | 41 | 0.110 |
Why?
| | Protein Isoforms | 2 | 2006 | 171 | 0.110 |
Why?
| | Time Factors | 5 | 2014 | 2548 | 0.110 |
Why?
| | Models, Biological | 3 | 2008 | 965 | 0.110 |
Why?
| | Glutamic Acid | 1 | 2008 | 75 | 0.110 |
Why?
| | Atherosclerosis | 1 | 2009 | 104 | 0.110 |
Why?
| | Blotting, Western | 4 | 2012 | 548 | 0.100 |
Why?
| | Protein Kinase C-delta | 2 | 2004 | 5 | 0.100 |
Why?
| | Palmitates | 1 | 2006 | 8 | 0.100 |
Why?
| | Histones | 2 | 2015 | 354 | 0.100 |
Why?
| | Calcium | 1 | 2009 | 526 | 0.090 |
Why?
| | Myoblasts | 1 | 2006 | 35 | 0.090 |
Why?
| | Rats, Zucker | 2 | 2003 | 5 | 0.090 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2006 | 50 | 0.090 |
Why?
| | Adipocytes | 3 | 2015 | 160 | 0.090 |
Why?
| | Serine | 1 | 2006 | 57 | 0.090 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 2006 | 174 | 0.090 |
Why?
| | Aging | 2 | 2008 | 521 | 0.090 |
Why?
| | Dietary Fats | 2 | 2006 | 209 | 0.090 |
Why?
| | C-Peptide | 1 | 2005 | 21 | 0.090 |
Why?
| | Allosteric Regulation | 1 | 2005 | 44 | 0.090 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2009 | 497 | 0.090 |
Why?
| | Muscle Fibers, Slow-Twitch | 1 | 2004 | 4 | 0.090 |
Why?
| | Electric Stimulation | 1 | 2005 | 103 | 0.090 |
Why?
| | Feedback, Physiological | 1 | 2005 | 51 | 0.090 |
Why?
| | Drug Industry | 1 | 2005 | 29 | 0.090 |
Why?
| | Muscular Atrophy | 1 | 2004 | 9 | 0.090 |
Why?
| | Muscle Fatigue | 1 | 2005 | 38 | 0.090 |
Why?
| | Biotechnology | 1 | 2005 | 34 | 0.090 |
Why?
| | Kidney Transplantation | 1 | 2006 | 166 | 0.080 |
Why?
| | Immunosuppressive Agents | 1 | 2006 | 195 | 0.080 |
Why?
| | Sports | 1 | 2004 | 29 | 0.080 |
Why?
| | Blood | 1 | 2004 | 25 | 0.080 |
Why?
| | Inflammation | 1 | 2009 | 643 | 0.080 |
Why?
| | Proto-Oncogene Proteins c-cbl | 1 | 2004 | 8 | 0.080 |
Why?
| | CCAAT-Enhancer-Binding Proteins | 1 | 2004 | 20 | 0.080 |
Why?
| | Adiponectin | 1 | 2004 | 22 | 0.080 |
Why?
| | Rats, Mutant Strains | 1 | 2003 | 12 | 0.080 |
Why?
| | Phosphotyrosine | 1 | 2003 | 16 | 0.080 |
Why?
| | Islets of Langerhans | 1 | 2005 | 213 | 0.080 |
Why?
| | Genome-Wide Association Study | 2 | 2015 | 145 | 0.080 |
Why?
| | Protein Kinase C-alpha | 1 | 2003 | 15 | 0.080 |
Why?
| | Oleic Acid | 1 | 2003 | 21 | 0.080 |
Why?
| | Adenosine Triphosphate | 1 | 2005 | 248 | 0.080 |
Why?
| | Cardiomyopathy, Dilated | 1 | 2003 | 17 | 0.080 |
Why?
| | Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2003 | 2 | 0.080 |
Why?
| | Physical Education and Training | 1 | 2003 | 30 | 0.080 |
Why?
| | Tyrosine | 1 | 2003 | 84 | 0.080 |
Why?
| | Regional Blood Flow | 1 | 2003 | 84 | 0.070 |
Why?
| | Blood Pressure | 2 | 2015 | 357 | 0.070 |
Why?
| | Cryptochromes | 2 | 2015 | 34 | 0.070 |
Why?
| | CLOCK Proteins | 2 | 2015 | 37 | 0.070 |
Why?
| | Period Circadian Proteins | 2 | 2015 | 61 | 0.070 |
Why?
| | Hydrocortisone | 2 | 2015 | 115 | 0.070 |
Why?
| | Stroke Volume | 1 | 2003 | 188 | 0.070 |
Why?
| | Phenotype | 1 | 2004 | 780 | 0.070 |
Why?
| | Up-Regulation | 2 | 2015 | 309 | 0.070 |
Why?
| | Diet | 1 | 2006 | 486 | 0.070 |
Why?
| | Reproducibility of Results | 2 | 2014 | 986 | 0.070 |
Why?
| | Reference Values | 3 | 2007 | 294 | 0.060 |
Why?
| | Pancreatic Neoplasms | 1 | 2003 | 193 | 0.060 |
Why?
| | Chronic Disease | 1 | 2003 | 532 | 0.060 |
Why?
| | Mutation, Missense | 2 | 2015 | 114 | 0.060 |
Why?
| | Mutation | 1 | 2005 | 1732 | 0.050 |
Why?
| | Proteins | 1 | 2004 | 600 | 0.050 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2013 | 523 | 0.050 |
Why?
| | Cell Membrane | 2 | 2009 | 420 | 0.050 |
Why?
| | Thinness | 1 | 2015 | 27 | 0.050 |
Why?
| | ARNTL Transcription Factors | 1 | 2015 | 23 | 0.050 |
Why?
| | Blood Pressure Determination | 1 | 2015 | 20 | 0.040 |
Why?
| | Histidine | 1 | 2015 | 33 | 0.040 |
Why?
| | Waist Circumference | 1 | 2015 | 48 | 0.040 |
Why?
| | Nucleic Acid Synthesis Inhibitors | 1 | 2014 | 12 | 0.040 |
Why?
| | Genetic Markers | 1 | 2015 | 104 | 0.040 |
Why?
| | Kynurenic Acid | 1 | 2014 | 2 | 0.040 |
Why?
| | Arginine | 1 | 2015 | 78 | 0.040 |
Why?
| | Transaminases | 1 | 2014 | 10 | 0.040 |
Why?
| | Genetic Loci | 1 | 2015 | 51 | 0.040 |
Why?
| | Central Nervous System | 1 | 2015 | 90 | 0.040 |
Why?
| | Greenland | 1 | 2014 | 1 | 0.040 |
Why?
| | Vascular Resistance | 1 | 2014 | 33 | 0.040 |
Why?
| | Carotid Artery, Common | 1 | 2014 | 17 | 0.040 |
Why?
| | Amino Acid Substitution | 1 | 2015 | 209 | 0.040 |
Why?
| | Blood-Brain Barrier | 1 | 2014 | 38 | 0.040 |
Why?
| | Sex Characteristics | 1 | 2015 | 132 | 0.040 |
Why?
| | 3' Untranslated Regions | 1 | 2014 | 73 | 0.040 |
Why?
| | Codon, Nonsense | 1 | 2014 | 32 | 0.040 |
Why?
| | GTP Phosphohydrolases | 2 | 2005 | 29 | 0.040 |
Why?
| | Gene Frequency | 1 | 2014 | 100 | 0.040 |
Why?
| | Aged | 3 | 2014 | 7419 | 0.040 |
Why?
| | Culture Media, Conditioned | 1 | 2013 | 42 | 0.040 |
Why?
| | Hypertriglyceridemia | 1 | 2013 | 7 | 0.040 |
Why?
| | Hemodynamics | 1 | 2014 | 168 | 0.040 |
Why?
| | Disease Susceptibility | 1 | 2013 | 93 | 0.040 |
Why?
| | Calorimetry, Indirect | 1 | 2013 | 24 | 0.040 |
Why?
| | Carbon Dioxide | 1 | 2013 | 60 | 0.040 |
Why?
| | Receptors, Interleukin-6 | 1 | 2012 | 6 | 0.040 |
Why?
| | Motor Neurons | 1 | 2014 | 120 | 0.040 |
Why?
| | Mice, Mutant Strains | 1 | 2013 | 271 | 0.040 |
Why?
| | Genotype | 1 | 2014 | 481 | 0.040 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2015 | 313 | 0.040 |
Why?
| | Carboxylic Ester Hydrolases | 1 | 2012 | 4 | 0.040 |
Why?
| | Interleukin-1beta | 1 | 2014 | 180 | 0.040 |
Why?
| | Body Composition | 1 | 2013 | 163 | 0.040 |
Why?
| | Animal Nutritional Physiological Phenomena | 1 | 2012 | 4 | 0.040 |
Why?
| | High Mobility Group Proteins | 1 | 2012 | 20 | 0.040 |
Why?
| | Methylation | 1 | 2012 | 108 | 0.040 |
Why?
| | DNA Cleavage | 1 | 2011 | 8 | 0.030 |
Why?
| | Sulfites | 1 | 2011 | 5 | 0.030 |
Why?
| | Mitochondria, Liver | 1 | 2012 | 40 | 0.030 |
Why?
| | Cytosine | 1 | 2011 | 22 | 0.030 |
Why?
| | Luminescent Measurements | 1 | 2011 | 33 | 0.030 |
Why?
| | 3T3-L1 Cells | 1 | 2011 | 73 | 0.030 |
Why?
| | Glycoproteins | 1 | 2012 | 171 | 0.030 |
Why?
| | Cell Lineage | 1 | 2012 | 196 | 0.030 |
Why?
| | Glucose Transporter Type 1 | 1 | 2011 | 39 | 0.030 |
Why?
| | Risk Reduction Behavior | 1 | 2011 | 97 | 0.030 |
Why?
| | Killer Cells, Lymphokine-Activated | 1 | 2010 | 2 | 0.030 |
Why?
| | Mice, Inbred NOD | 1 | 2012 | 385 | 0.030 |
Why?
| | Cell Degranulation | 1 | 2010 | 14 | 0.030 |
Why?
| | K562 Cells | 1 | 2010 | 32 | 0.030 |
Why?
| | Genes, Mitochondrial | 1 | 2010 | 4 | 0.030 |
Why?
| | Polymerase Chain Reaction | 1 | 2011 | 431 | 0.030 |
Why?
| | Ouabain | 1 | 2009 | 9 | 0.030 |
Why?
| | Interleukin-2 | 1 | 2010 | 160 | 0.030 |
Why?
| | Pyrazoles | 1 | 2009 | 43 | 0.030 |
Why?
| | DNA Primers | 1 | 2010 | 300 | 0.030 |
Why?
| | Pyrimidines | 1 | 2009 | 66 | 0.030 |
Why?
| | Receptors, Transforming Growth Factor beta | 1 | 2009 | 22 | 0.030 |
Why?
| | Adipokines | 1 | 2009 | 24 | 0.030 |
Why?
| | Chemokine CCL2 | 1 | 2009 | 56 | 0.030 |
Why?
| | Lipogenesis | 1 | 2009 | 22 | 0.030 |
Why?
| | Nuclear Receptor Subfamily 1, Group D, Member 1 | 1 | 2008 | 2 | 0.030 |
Why?
| | Hexokinase | 1 | 2008 | 8 | 0.030 |
Why?
| | Exocytosis | 1 | 2009 | 60 | 0.030 |
Why?
| | Transcription, Genetic | 1 | 2013 | 808 | 0.030 |
Why?
| | Receptors, Kainic Acid | 1 | 2008 | 1 | 0.030 |
Why?
| | Receptors, Metabotropic Glutamate | 1 | 2008 | 6 | 0.030 |
Why?
| | Apolipoproteins E | 1 | 2009 | 72 | 0.030 |
Why?
| | Flavoproteins | 1 | 2008 | 29 | 0.030 |
Why?
| | Haplorhini | 1 | 2008 | 15 | 0.030 |
Why?
| | Antigens, CD4 | 1 | 2009 | 123 | 0.030 |
Why?
| | Oncogene Protein v-akt | 1 | 2008 | 11 | 0.030 |
Why?
| | Receptors, AMPA | 1 | 2008 | 28 | 0.030 |
Why?
| | Carrier Proteins | 1 | 2013 | 614 | 0.030 |
Why?
| | Carbohydrate Metabolism | 1 | 2008 | 38 | 0.030 |
Why?
| | Inflammation Mediators | 1 | 2009 | 132 | 0.030 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 1 | 2008 | 104 | 0.030 |
Why?
| | Treatment Outcome | 1 | 2015 | 2519 | 0.030 |
Why?
| | NF-kappa B | 1 | 2010 | 392 | 0.030 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2008 | 119 | 0.030 |
Why?
| | Protein Transport | 1 | 2009 | 324 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2009 | 695 | 0.030 |
Why?
| | Polymorphism, Restriction Fragment Length | 1 | 2007 | 27 | 0.030 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2008 | 276 | 0.030 |
Why?
| | Cell Line, Tumor | 1 | 2010 | 857 | 0.030 |
Why?
| | Nuclear Respiratory Factor 1 | 1 | 2006 | 2 | 0.020 |
Why?
| | Interferon-gamma | 1 | 2009 | 473 | 0.020 |
Why?
| | Homeodomain Proteins | 1 | 2008 | 192 | 0.020 |
Why?
| | Body Size | 1 | 2006 | 17 | 0.020 |
Why?
| | Polymorphism, Genetic | 1 | 2007 | 162 | 0.020 |
Why?
| | Blood Chemical Analysis | 1 | 2006 | 17 | 0.020 |
Why?
| | Cell Cycle Proteins | 1 | 2008 | 276 | 0.020 |
Why?
| | Charcot-Marie-Tooth Disease | 1 | 2005 | 5 | 0.020 |
Why?
| | Cytoskeletal Proteins | 1 | 2006 | 140 | 0.020 |
Why?
| | Thiazoles | 1 | 2005 | 35 | 0.020 |
Why?
| | Flavonoids | 1 | 2005 | 36 | 0.020 |
Why?
| | Imidazoles | 1 | 2005 | 56 | 0.020 |
Why?
| | Family | 1 | 2006 | 150 | 0.020 |
Why?
| | MAP Kinase Kinase Kinases | 1 | 2005 | 59 | 0.020 |
Why?
| | Pyridines | 1 | 2005 | 81 | 0.020 |
Why?
| | Apoptosis | 1 | 2010 | 876 | 0.020 |
Why?
| | Metabolic Syndrome X | 1 | 2006 | 116 | 0.020 |
Why?
| | MADS Domain Proteins | 1 | 2004 | 3 | 0.020 |
Why?
| | MAP Kinase Kinase 1 | 1 | 2004 | 8 | 0.020 |
Why?
| | Myogenic Regulatory Factors | 1 | 2004 | 13 | 0.020 |
Why?
| | Osmotic Pressure | 1 | 2004 | 13 | 0.020 |
Why?
| | Protein Kinase C-epsilon | 1 | 2004 | 9 | 0.020 |
Why?
| | COS Cells | 1 | 2004 | 185 | 0.020 |
Why?
| | DNA, Complementary | 1 | 2004 | 183 | 0.020 |
Why?
| | Mitogen-Activated Protein Kinase Kinases | 1 | 2004 | 52 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2009 | 1181 | 0.020 |
Why?
| | Swine | 1 | 2004 | 269 | 0.020 |
Why?
| | Cytosol | 1 | 2004 | 136 | 0.020 |
Why?
| | Temperature | 1 | 2004 | 251 | 0.020 |
Why?
| | 3-O-Methylglucose | 1 | 2003 | 15 | 0.020 |
Why?
| | Models, Genetic | 1 | 2004 | 234 | 0.020 |
Why?
| | Exercise Test | 1 | 2004 | 148 | 0.020 |
Why?
| | Lipodystrophy | 1 | 2002 | 8 | 0.020 |
Why?
| | Membrane Potentials | 1 | 2003 | 157 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2006 | 2095 | 0.020 |
Why?
|
|
Zierath's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|